James P. Holland to Join Humana as Medicaid President
James P. Holland to Join Humana as Medicaid President
Humana Inc. (NYSE: HUM) today announced that James “J.P.” Holland will join the company as senior vice president and President of Medicaid, effective August 17. In this role, Holland will lead the company’s growing Medicaid business, which currently serves more than 1.6 million members in 11 states. Holland will report to Aaron Martin, President of Insurance.
“Medicaid is an important part of how we deliver on Humana’s purpose, helping some of the most vulnerable populations access the care and support they need to achieve their best health,” said Aaron Martin, President of Insurance at Humana. “J.P. brings deep expertise leading government-sponsored healthcare plans and maintaining strong relationships with state and provider partners. His experiences and insights will be invaluable as we continue to grow our Medicaid business and better serve our Medicaid members.”
Holland most recently served as President and CEO of Johns Hopkins Health Plans, where he led Medicaid, Medicare and other government-sponsored businesses. Prior to Johns Hopkins Health Plans, he was CEO of the Alliance Business at Elevance Health and also held leadership roles at Amerigroup and WellCare Health Plans. Earlier in his career, Holland served as a U.S. Navy pilot. He holds a bachelor’s degree in economics from the U.S. Naval Academy and an MBA from the Wharton School of the University of Pennsylvania.
About Humana
Humana is a leading U.S. healthcare company. Through our Humana insurance services, and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
Investors: Lisa Stoner - Humana Investor Relations; (502) 580-2652;
lstamper@humana.com
Media: Mark Taylor - Humana Corporate Communications; (317) 753-0345;
MTaylor108@humana.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260810551786/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term